Urinary albumin levels in the normal range determine arterial wall thickness in adults with Type 2 diabetes: a FIELD substudy

Aim  Cardiovascular disease (CVD) rates are substantially higher among patients with Type 2 diabetes than in the general population. The objective of this study was to identify the determinants of carotid intima media thickness (IMT) in patients with Type 2 diabetes.

[1]  James D. Best,et al.  The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481] , 2004, Cardiovascular diabetology.

[2]  Therapies Study Investigators.  The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481] , 2004 .

[3]  L. Bouter,et al.  Impact of diabetes duration and cardiovascular risk factors on mortality in type 2 diabetes: the Hoorn Study , 2002, European journal of clinical investigation.

[4]  C. Langefeld,et al.  Heritability of Carotid Artery Intima-Medial Thickness in Type 2 Diabetes , 2002, Stroke.

[5]  A. Hofman,et al.  Carotid intima-media thickness at different sites: relation to incident myocardial infarction; The Rotterdam Study. , 2002, European heart journal.

[6]  A. Smit,et al.  Difference in the relation between urinary albumin excretion and carotid intima-media thickness in nondiabetic and type 2 diabetic subjects. , 2002, Diabetes care.

[7]  H. Parving,et al.  Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. , 2002, Diabetes.

[8]  M. Nieminen,et al.  Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study , 2002, Journal of hypertension.

[9]  Moyses Szklo,et al.  Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987-1998. , 2002, American journal of epidemiology.

[10]  S. Yusuf,et al.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. , 2001, JAMA.

[11]  M. Matsuhisa,et al.  Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease. , 2000, Diabetes care.

[12]  V. Mohan,et al.  Intimal medial thickness of the carotid artery in South Indian diabetic and non-diabetic subjects: the Chennai Urban Population Study (CUPS) , 2000, Diabetologia.

[13]  Eary,et al.  CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS , 2000 .

[14]  M. Schroll,et al.  Urinary albumin excretion. An independent predictor of ischemic heart disease. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[15]  M. Kaps,et al.  Frontal bone windows for transcranial color-coded duplex sonography. , 1999, Stroke.

[16]  G D Lowe,et al.  Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. , 1999, Stroke.

[17]  L. Bouter,et al.  Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[18]  G. Jensen,et al.  Endothelial haemostatic factors are associated with progression of urinary albumin excretion in clinically healthy subjects: a 4-year prospective study. , 1999, Clinical science.

[19]  M. Rewers,et al.  Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study. , 1998, Diabetes care.

[20]  T. Temelkova-Kurktschiev,et al.  Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individuals , 1998, Diabetologia.

[21]  H. Hein,et al.  Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. , 1998, Circulation.

[22]  A. Folsom,et al.  Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. , 1997, American journal of epidemiology.

[23]  Arno W. Hoes,et al.  Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. , 1997, Circulation.

[24]  S. Haffner,et al.  Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS). , 1997, Stroke.

[25]  P. Savage,et al.  Duration of diabetes and carotid wall thickness. The Insulin Resistance Atherosclerosis Study (IRAS). , 1997, Stroke.

[26]  L. Niskanen,et al.  Carotid artery intima-media thickness in elderly patients with NIDDM and in nondiabetic subjects. , 1996, Stroke.

[27]  M. Sampson,et al.  Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. , 1996, Journal of the American College of Cardiology.

[28]  S. Azen,et al.  Reduction in Carotid Arterial Wall Thickness Using Lovastatin and Dietary Therapy , 1996, Annals of Internal Medicine.

[29]  Harris Jp,et al.  Albuminuria is an Independent Predictor of Carotid Intima-Media Thickness and Atherosclerosis in NIDDM Patients , 1995 .

[30]  R. Bergman,et al.  The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results. , 1995, Annals of epidemiology.

[31]  D. Yue,et al.  Albuminuria is an Independent Predictor of Carotid Intima-Media Thickness and Atherosclerosis in NIDDM Patients , 1995, Diabetes Care.

[32]  A. Keech,et al.  Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. , 1995, Circulation.

[33]  C. Furberg,et al.  Reduction in coronary events during treatment with pravastatin. PLAC I and PLAC II Investigators. Pravastatin Limitation of Atherosclerosis in the Coronary Arteries. , 1995, The American journal of cardiology.

[34]  B. Fagerberg,et al.  Urinary albumin excretion is associated with the intima‐media thickness of the carotid artery in hypertensive males with non‐insulin‐dependent diabetes mellitus , 1995, Journal of hypertension.

[35]  A. Maggioni,et al.  Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. , 1993, Journal of the American College of Cardiology.

[36]  J. Salonen,et al.  Ultrasound B-mode imaging in observational studies of atherosclerotic progression. , 1993, Circulation.

[37]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[38]  P. Touboul,et al.  Prevalence and Determinants of Carotid Atherosclerosis in a General Population , 1992, Stroke.

[39]  A. Donker,et al.  Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus , 1992, The Lancet.

[40]  J. Salonen,et al.  Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[41]  The British Regional Heart Study , 1991 .

[42]  M. Mullee,et al.  Microalbuminuria in Diabetes: A Population Study of the Prevalence and an Assessment of Three Screening Tests , 1988, Diabetic medicine : a journal of the British Diabetic Association.

[43]  C. Mogensen,et al.  Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. , 1984, The New England journal of medicine.

[44]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.